LOS ALTOS, Calif. & DURHAM, N.C.--(BUSINESS WIRE)--PMWC International, the preeminent precision medicine conference leader that since 2009 has attracted recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors, today announced that Duke Health and Duke University will co-host the first-ever East Coast Precision Medicine World Conference in North Carolina on May 24-25, 2017. Hundreds of healthcare leaders, representing a variety of companies, technologies, researchers and medical centers with leadership roles in precision medicine are expected to attend.
A total of 100 speakers (including N.C. Governor Roy Cooper) from healthcare and biotechnology sectors will be featured in more than 35 sessions; topics include:
- how data science advances precision medicine
- impact of technology to drive genomics and medical practice
- latest on data and regulatory policies
- emergence of single cell genomics and infectious disease monitoring
- how mobile health and other advancements are changing the face of healthcare
- clinical models for precision medicine and importance of patient engagement
The conference will recognize five individuals who have played and continue to play a significant role in transforming today’s healthcare by advancing precision medicine into the clinic. This includes Dr. Francis S. Collins, director of the National Institutes of Health, who played a vital role in leading the human genome sequencing project as well as major government initiatives such as the 1-million-person All of Us cohort program. Additional honorees include Dr. Elaine Mardis, Nationwide Children’s Hospital; Kathy Giusti, Multiple Myeloma Research Foundation; Dr. Keith Yamamoto, UCSF; and Mark Levin, Third Rock Ventures.
“Duke established itself as a founder and recognized leader in precision medicine, embracing it both scientifically and clinically. For us, it is a logical choice to bring the PMWC to Duke and to allow us to highlight what is happening on our campus, in our region and on the East Coast,” said Dr. Ralph Snyderman, chancellor emeritus of Duke University, who is chairing the program together with Dr. Geoff Ginsburg, the director of the Duke Center for Applied Genomics & Precision Medicine.
“PMWC’s expertise in showcasing practical content and bringing together recognized and established leaders across the field helps close the knowledge gap between different sectors and catalyzes cross-functional dialog and collaboration, which can benefit all conference attendees,” said Tal Behar, co-founder and president of PMWC International.
About PMWC International
Since 2009, recognized as a vital cornerstone for all constituents of the healthcare and biotechnology community, PMWC (pmwcintl.com/) provides an exceptional forum for the exchange of information about the latest advances in technology (e.g., DNA sequencing technology), in clinical implementation (e.g., cancer and beyond), research, and in all aspects related to the regulatory and reimbursement sectors.